Alle 11 emner som modtog VIRAMUNE + ZDV, som blev testet for fænotypisk resistens, var resistente overfor nevirapin i 6 måneder.
All 11 subjects receiving VIRAMUNE + zidovudine who were tested for phenotypic resistance were resistant to nevirapine by six months.